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Background: Breast cancer is a major life-threatening public health problem of great concern. 
Long-term increases in the incidence of the disease are being observed in both industrialized and 
developing world.  
Methods: During 1995-99, 137 biopsy proven breast cancer cases underwent surgical treatment at 
Tikur Anbessa Hospital, Addis Ababa. Of these cases, records of 125 were retrieved and analyzed 
to assess the pattern and treatment outcome of the disease.   
Results: The median age of females was 40 years. The median duration of the presenting symptom 
on admission was nearly 1 year.  Clinically, majority of cases had stage III disease. Invasive ductal 
carcinoma was the most frequent type.  Eighty-nine (71.2%) patients underwent modified radical 
mastectomy. During a short follow-up, 50 (45.9%) of 109 patients were seen with recurrences. Only 
4 cases were seen at 5 or more years.  
Conclusion: In our series, breast cancer affected mainly young women; patients presented 
excessively late a probable contributor to the high rate of early relapse. Follow-up was poor. Public 





Breast cancer is a major public health problem 
of great importance1. It is a stressful disease to 
those affected2. Worldwide, increase in the 
incidences of breast cancer is being observed3. 
The increase is considerable below the age of 50 
years. After menopause, the incidence rates 
continue to rise, but less dramatically1.  In 
general, in the less affluent and third world 
countries, the same but much lower pattern of 
increase with age is seen4-6. Diagnostic delays of 
3-6 months are associated with advanced stage 
breast cancer and lower survival. Detection and 
treatment of cancer at an early stage improves 
the prospects for long-term survival7. In 
Ethiopia, there is no cancer registry and the 
incidence of the disease is unknown. The aim of 
this retrospective study was to analyze the 
pattern and treatment outcome of breast cancer 
in a teaching hospital. 
 
Patients and Methods 
 
In the years 1995 to 1999, 137 histologically 
confirmed breast cancer patients underwent 
surgery at Tikur Anbessa Hospital (TAH), 
Addis Ababa. Of these, the records of 125 cases 
were retrieved and analyzed. TAH is a central 
tertiary referral hospital with adult surgical bed 
capacity of about 200. Information obtained 
from the records of patients included 
demographic characteristics, clinical and  
 
 
pathological description of cancer, treatment 
and outcome. Diagnosis of metastases was 
based on clinical evaluation, cytohistological 
examination, or radiological studies. TNM8 
crude stage of the disease was based on 
information stated in patients’ records.  
 
During the years under review, TAH had no 
established breast cancer treatment protocol and 
hence decision on the type of surgical procedure 
was made mainly by the individual surgeon. 
Breast conserving therapy (BCT) with axillary 
node dissection, most probably due to patient 
preference, was offered in only 12 patients; 11 
of them had stage II disease. One patient with 
stage IIIb disease also underwent 
quadrantectomy because of refusal to undergo 
mastectomy.  Modified radical mastectomy with 
axillary node dissection was performed in 
patients with stage I and II.  Toilet mastectomy 
was performed for mobile ulcerated fungating 
tumours with or without distant metastases.  
 
Postoperatively, ipsilateral chest or axillary 
subcutaneous or skin nodule verified as breast 
carcinoma was termed as local recurrence. Data 
were collected on a pre format and entered into 
a computer. Data analysis was performed using 
Epi info version 6 software and relevant 
statistical analysis was done using the available 
statistical package. 
 





The majority (55.2%) of the patients were in the 
30-49 age group. Only 5% were 25 years old or 
below (Table 1 and Fig.1).  The age for females 
ranged between 20 and 80 years with a mean of 
42.4±11.9. In males the ages ranged from 37 to 
80 years with a median 55.8±13.3. Out of 112 
females, 13.4% and 70.5% were under the age 
of 30 and 50 years, respectively. Most patients 
were premenopausal women.  The median parity 
was 4±2 but 18.1% were young nulliparous 
women.  Majority of cases were Amhara by 
ethnicity and Christian.   
 
The median duration of the presenting symptom 
on admission was 11.5±19.3 months (Table 2). 
Of 118 patients with documented chief 
complaints, 92.4% had initially painless breast 
lump. Breast pain without lump or nipple 
discharge as the main presenting feature was 
rare. About 50% of cases had locally advanced 
lesion and a quarter presented with ulcerated or 
fungating lesions.  History of pregnancy or 
lactation was documented in 103 cases; 12 were 
pregnant or lactating at or after the detection of 
breast lesion and 3 became pregnant during 
breast cancer treatment; 8 of these had stage III 
disease. History of benign breast disease (6%), 
contralateral breast (3%) or non-breast cancer 
was rare. The most common signs were breast 
mass and axillary metastasis.   
 
Sixty-seven (54%) patients had mobile and 
20(16%) fixed ipsilateral axillary lymph nodes. 
The location of lesions was specified in 111 
cases; 49% were in the upper outer quadrant. 
Sixty per cent (n= 118) of cases had tumors 
larger than 5 cm in diameter. Lesions fixed to 
the underlying muscles (34 cases), mainly the 
pectoral muscles, were not rare. Twelve (10%) 
patients had distant metastases, 6 in the lung, 5 
in bone, and 4 in the liver. Clinically, majority 
of cases (60.2%) had stage III and IV disease, in 
nearly all locally advanced stage III disease. 
Satellite skin nodules (7%), supraclavicular 
(6%) or contra lateral axillary (2%) node 
metastases were rare.  No case of Stage I disease 
was not recorded. Ductal invasive 
adenocarcinoma was the most frequently 
(77.6%) reported pathological type (Table 3). 
Other rare lesions included colloid/mucoid, 
comedo, papillary, or squamous cell carcinoma, 
lymphoma, and sarcoma (1 each).   Eighty-nine 
patients (71.8%) underwent modified radical 
mastectomy and 103, axillary dissections.  In 21 
patients, toilet mastectomy was performed for 
ulcerative/fungating tumors. Only 12 cases 
underwent breast-conserving surgery with 
axillary dissection, 9 quadrantectomy.  Forty-
two patients received combined or single 
adjuvant therapy including radiotherapy (29), 
chemotherapy (20), tamoxifen (19), and or 
oophorectomy (8 patients).Out of 10 BCT cases 
that received adjuvant therapy only 6 had 
radiotherapy.  
 
Table 1. Demographic features 
Age 
(Years) 
Range: 20 – 80 
*Mean: 44 + 13 
M:F Ratio 1:8 
Ethnicity (N=115) No.                         %     
Amhara                  63.5 
Oromo                   15.7 
Guraghe                  8.7 
Tigre                       7.8 
Religion Christians:             86.4 
Moslems:              11.8 
Others    :                1.8 
* Mean +  sd 
Postoperative complications occurred in 30 
patients, frequently wound collection and 
infection. One case, a 27-year-old female with 
bilateral invasive ductal carcinoma with lung, 
vertebral and liver metastases died in hospital 
following cytoreductive mastectomy, 
chemotherapy and radiation therapy.  
 
Follow-up was possible in 109 cases (87.9%) 
for a median duration of 10 months. Of these, 
58.7% had follow-up for 1 year or less, only 4 
for 5 years or more. Fifty patients (45.9%) were 
seen with recurrences (46 females); 16 (32%) 
had local, 11 (22%) distant, and 21 (42%) had 
both local and distant recurrences. All the 
recurrences were following toilet (12cases) or 
radical mastectomy (38 cases) with or without 
adjuvant therapy. The most frequent sites of 
recurrence or metastasis were the skin (28), 
ipsilateral axilla (17), lung (17) and bone (10 
cases). Two (4%) died from the disease. 
Condition of 15 (12%) was unknown; 11 had 
stage IIIB or IV disease.  During a mean follow-
up time of 2 years, all 12 BCT cases were seen 
with no evidence of local or distant recurrence. 
Short-term clinical disease-free or improved 
survival was observed in cases of stage II 
disease regardless of age and in those that 
received multimodality therapy.  
 




Table 2. Duration and clinical features in 125 cases of breast cancer, TAH, 1995-99 
 
 
 Duration*                                                              17±19 (1-108) months                                           
 Main symptom (n= 118)         Per cent                Associated symptoms              Per cent 
 Breast lump or mass                 96.6                       Nipple retraction                        29.6 
 Breast pain without lump           2.5                       Fungated/ ulcerated lesion         24.8 
 Nipple discharge                        0.8                       Nipple discharge                        16.8                     
                                                                                Itchy nipple                                5.6          
  
  Signs                                      Per cent                Signs                                    Per cent 
  Breast lump or mass                96.8                Lesion fixed to muscle             27.2 
  Lesion fixed to skin                 50.4                Ulcerated/ fungating lesion      25.6 
  Nipple retraction                      47.2                Nipple discharge                      13.6 
  Peau d’orange skin                  44.0                Axillary adenopathy                 67.2 
  Dimpled skin                           32.8     
      
 Location of breast lesion (n= 111)               Stage of disease (n= 123)     Per cent 
 Outer quadrant                         57.7                 Early                                         39.8                  
 Central                                     24.3                 Advanced                                  60.2 
 Medial quadrant                          18.0                                                                                                  






Table 3.  Pathology, Procedure, and Complications in 125 Breast Cancer Cases, TAH, 1995-99 
 
 
  Pathologic types                                    %           Procedure (n=124)                       %               
 
      Ductal invasive adenocarcinoma     77.6            Radical mastectomy                     73.4   
      Breast carcinoma                               8.0             Simple mastectomy                     16.9 
      Invasive lobular carcinoma               6.4              Quadrantectomy                           7.3 
      Medullary or colloid carcinoma        4.8             Lumpectomy                                 2.4 
      Inflammatory carcinoma                   0.8              Axillary node dissection             82.4       
      Undifferentiated carcinoma               0.8               Oophorectomy                             6.4 
       Sarcoma/lymphoma                          1.6       
  
  Postoperative complication (n= 30)   %              Condition at last visit (n= 109)   % 
 
       Wound seroma                               10.4               Local recurrence                         14.7 
       Wound infection                              9.6                Distant metastases                       8.8 
        Skin necrosis/separation                 2.4                Disease free survival                 47.2                 
        Pneumonia/thrombophlebitis          1.6                Dead from breast cancer             1.6 
        In hospital death                              0.8         














Breast cancer development increases with age, 
beginning to rise at approximately age 30 years2.  
In this study, 13.4% of cases were under 30 
years of age. Most breast cancers occur during 
the postmenopausal years. Among Japanese 
women, however, no postmenopausal incidence 
risk occurs; it is puzzling6.  In our series as well, 
in conformity also with other African 
experiences9,10, most women with breast cancer 
were in the premenopausal state, about 70% less 
than 50 years of age.  
 
In the US, nearly 85% of women with newly 
diagnosed breast cancer have disease that is 
clinically limited to the breast or regional 
nodes11. In this series, the median duration of 
the presenting symptom at admission was 11.5 
months and 60% of 118 cases had tumors larger 
than 5 cm in diameter, findings similar to those 
of African series9,10,12 disclosing excessive late 
presentation and advanced stage of the disease. 
Carter et al13 reported nodal metastases at 
diagnosis of around 40%; this was 67.2% in our 
series. Globally and in this series as well, in 
both sexes and all ages, infiltrative ductal and 
lobular breast carcinomas are the most common 
histological types accounting for 61-80% and 5-
10% of cases, respectively2,14-17.  
 
Breast carcinoma in men accounts for 0.5% of 
all breast cancers in the United States (18) and 
2.4% to 15% in African series19, 10.4% in the 
present study. The reported median age of breast 
cancer in men varies from 56 to 59.6 years 14,20, 
55 years in this series.  
 
The treatment of male and female breast cancer 
are similar14. Detection and excision of the 
primary tumor at an early stage improves the 
prospects for long-term survival7. In women 
with clinically positive axillary nodes, modified 
radical mastectomy and axillary dissection are 
excellent to achieve and maintain local control 
of breast cancer obviating radiation therapy2,21.  
For breast conserving surgery (BCT) to be 
successful, the tumor must be small confined to 
a quadrant and the patient must undergo 
radiotherapy11,17. Few cases underwent BCT in 
this series. As was also observed in 8 of 12 
patients in this study, pregnant patients have 
more advanced stage cancer and radio- or 
chemotherapy is risky before 30 weeks of 
gestation. Modified radical mastectomy without 
delay is the best option in pregnant women with 
stage I to III cancer22.  
 
The primary goal of treatment of metastatic 
breast cancer remains palliation of symptoms 
and improvement of the quality of life23. 
Effective control of locally advanced or 
recurrent disease, as was routinely attempted for 
the former in our series, is important because 
uncontrolled local disease significantly impairs 
the quality of life causing ulcerations, bleeding, 
foul discharge, debilitating limb edema and 
pain24.  
 
Recurrence of breast cancer is psychologically 
devastating indication of therapeutic failure 25,26. 
An overall locoregional relapse rate of between 
5% and 30% has been reported26 with a palpable 
mass appreciable in 70 to 90% of cases27.  
Numerous surgical studies show that the risk of 
locoregional failure is directly proportional to 
the extent of axillary lymph node involvement 
and the size of primary tumor21,28-31. Most 
locoregional relapses develop in the skin of the 
chest, a harbinger of distant metastases23,26,28. 
Following axillary dissections, axillary nodal 
recurrences are rare29; 34% axillary relapse rate 
in our series was probably due to an initial 
advanced disease. In this study, during a short 
postoperative follow-up, 50 of 109 cases 
developed local or distant recurrences. As cited 
by Zavosteky and Gardner, several studies have 
found that 88 to 94% of recurrences are at or 
near the primary site32, 74% in this series.  
 
This study is limited by its retrospective design, 
lack of cancer registry and the relatively small 
number of cases.  However, it appears that 
breast cancer affects young age group and 
majority present late. General guiding principles 
of breast cancer therapy are early detection and 
aggressive local treatment to prolong survival. 
In healthcare facilities where timely 
commencement of adjuvant therapy is restricted 
or where the therapy is unaffordable or 
inaccessible, mastectomy should be the initial 
option. Effective control of locally advanced or 
recurrent disease may improve quality of life of 
a patient and should be attempted in selected 
cases. 
 
Public awareness of the disease to identify 
patients with localized disease is important in 
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the pursuit to cure breast cancer. Patients with 
symptoms that could be due to breast cancer 
should be referred without delay for specialist 
assessment.  To uncover the magnitude of the 
disease in Ethiopia and to produce national 
breast cancer treatment guidelines a 
collaborative multicenter study is desirable. 




The medical records unit of Tikur Anbessa 
Hospital cooperated in patient chart retrieval. 
Grateful thanks are also due to all who 
participated in the care of the patients. Ato 
Kidane Mariam Woldeyesus, Addis Ababa 
University Faculty of Medicine, assisted in data 
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